Akebia Therapeutics, Inc. (AKBA)
1.365
-0.08
(-5.21%)
USD |
NASDAQ |
Jan 23, 16:00
1.37
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Research and Development Expense (TTM): 42.02M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 6.828B |
| Pfizer Inc. | 10.13B |
| Theravance Biopharma, Inc. | 37.97M |
| Zevra Therapeutics, Inc. | 16.83M |
| Organon & Co. | 405.00M |